摘要
心房颤动的类型包括：初发心房颤动（首次发现，不论其有无症状和能否自行复律）、阵发性心房颤动（持续时间〈7天，一般〈48h，多为自限性）、持续性心房颤动（持续时间〉7天，一般不能自行复律，药物复律的成功率较低，常需电复律）、永久性心房颤动（复律失败或复律后24h内又复发，可以是心房颤动的首发表现或由反复发作的心房颤动发展而来）。有些患者不能得到心房颤动的病史，尤其无症状或症状轻微的患者，
出处
《心电学杂志》
2008年第1期10-13,共4页
Journal of Electrocardiology(China)
参考文献20
-
1Levy S, Camm AJ, Saksena S, et al. lntenational consensus on nomenclature and classification of atrial fibrillation:A collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol, 2003, 14:443-445.
-
2Lip GY, Tello-Montoliu A. Management of atrial fibrillation. Heart, 2006, 92: 1177-1182.
-
3Fuster V, Ryden LE, Cannom DS, et al. ACC / AHA / ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines. J Am Coll Cardiol, 2006, 48: 854-906.
-
4Seidl K, Rameken M, Drogemuller A, et al. Embolic events in patients with atrial fibrillation and effective anticoagulation:value of transesophageal echocardiography to guide direct-current cardiovertion. Final results of the Ludwigshafen Observational Cardiovertion Study. J Am Coll Cardiol, 2002, 39:1432-1442.
-
5Naccarelli GV, Wolbrette DL, Khan M, et al. Old and new antiarrhythmic drugs for convening and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol, 2003, 91:15 -26D.
-
6Chiladakis JA, Kalogeropoulos A, Patsouras N, et al. lbutilide added to propafenone for the conversion of atrial fibrilation and atrial fluter. J Am Coll Cardiol, 2004, 44: 859-863.
-
7Singh BN, Singh SN, Reda DJ, et al. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med, 2005, 352:1861-1872.
-
8Pedersen OD, Bagger H, Keller N, et al. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation, 2001, 104: 292-296.
-
9Healey JS, Baranchuk A, Crystal E, et al. Prevent of atrial fibrillation with angiotensin- converting enzyme inhibiters and anglotensin receptor blockers. J Am Coll Cardiol, 2005, 45:1832- 1839.
-
10Madrid AH, Bueno MG, ReboUo JM, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting pesistent atrial fibrillation: A prospective and randomized study. Circulation, 2002, 106: 331-336.
同被引文献8
-
1胡大一,孙艺红.心房颤动的病因和流行病学[J].中国实用内科杂志,2006,26(2):163-164. 被引量：42
-
2陈灏珠.心房颤动诊断与治疗的进展和展望[J].中国实用内科杂志：临床前沿版,2006,26(1):82-85. 被引量：44
-
3宋晓漪,郭杰.阵发性房颤并心衰药物复律治疗的临床观察[J].中华急诊医学杂志,2007,16(1):87-89. 被引量：6
-
4国伟,郑宗锷.现代心脏内科学[M].长沙:湖南科学技术出版社,2002:581.
-
5EugeneBraunwald 陈灏珠 译.心脏病学[M].北京：人民卫生出版社,2000.777-778.
-
6林荣，郭继红．心血管疾病的现代观念[M]．北京：北京大学医学出版社,2004：283-290．
-
7赵梦华,石建平,田洪森.心房颤动的药物治疗策略[J].临床急诊杂志,2003,4(3):40-42. 被引量：7
-
8朱俊.胺碘酮的临床应用[J].医师进修杂志,2004,27(1):45-47. 被引量：88
二级引证文献3
-
1余强芳,彭渝.心脏术后房颤危险因素与护理研究进展[J].护理实践与研究,2012,9(4):136-137. 被引量：6
-
2张任权,古军恩,李伟华,温茂森,何华芳.合贝爽静脉注射和口服序贯治疗快速房颤疗效观察[J].岭南急诊医学杂志,2012,17(4):251-252. 被引量：1
-
3莫薇.浅谈可导致心脏病患者在手术后发生房颤的危险因素[J].当代医药论丛,2015,13(6):89-90. 被引量：1
-
1刘泽银,黄平.索他洛尔转复房颤临床观察[J].航空航天医药,2005,16(4):43-43.
-
2叶红华.房颤自行复律可能性的初步探讨[J].宁波医学,2000,12(4):163-165.
-
3甘文云,唐其柱,王蕾,田青,周恒.高敏C反应蛋白在房颤中的意义及其与心功能的关系[J].实用医学杂志,2009,25(4):586-587. 被引量：10
-
4马乐乐,黎明江.心房颤动患者血浆高密度脂蛋白胆固醇水平变化的临床研究[J].海南医学,2011,22(22):4-6. 被引量：3
-
5陈华,徐伟民.胺碘酮与普罗帕酮维持心房颤动复律后窦性心律的疗效对比[J].现代实用医学,2008,20(9):696-697.
-
6田建英,宋霄.不同剂量乙胺碘呋酮维持老年房颤患者复律后窦性心律的疗效观察[J].中国老年学杂志,2006,26(10):1408-1409. 被引量：3
-
7王晓波,廖于,罗平,潘光斌.不同临床因素时房颤患者炎症标志物的浓度变化及意义[J].重庆医学,2010,39(14):1816-1818. 被引量：16
-
8陈守宏,李东野.初发房颤85例临床分析[J].陕西医学杂志,2009,38(6):714-715.
-
9吴美玲.心室颤动自行复律1例[J].中国实用心电杂志,1997,18(2):83-83.
-
10林小虬,余子昌,黄英如.论住院期间发作房颤小于48h紧急复律治疗后抗凝4周的必要性[J].北方药学,2016,13(12):154-155.
